Zydus Therapeutics Inc.

This study is a long-term follow-up to test the safety and effectiveness of the drug saroglitazar magnesium in people with primary biliary cholangitis (PBC), a chronic liver disease. It is open to 150 adults who successfully completed the first part of the research. The main goal…

This is an early safety study to see how a drug called saroglitazar magnesium is processed by the body in people who have moderate liver damage from a specific type of liver disease. It will involve 6 participants who have this condition. The main goal is to measure drug levels i…

This study aims to understand how a drug called Saroglitazar is processed by the body in people with liver damage caused by a specific type of liver disease. It will compare 30 participants with mild, moderate, or severe liver damage to people with normal liver function. The main…